Pfizer–BioNTech vaccine approved for Australian children aged 5 to 11
The Therapeutic Goods Administration has provisionally approved the use of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11 in Australia, with rollout scheduled to begin on 10 January 2022 following an independent recommendation.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthPfizer–BioNTech vaccine approved for Australian children aged 5 to 11
Sign in or subscribeBrowse free archive reportsThe Therapeutic Goods Administration has provisionally approved the use of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11 in Australia, with rollout scheduled to begin on 10 January 2022 following an independent recommendation.